Ilona W. Surick

Public Health and Preventive Medicine

420 Acorn Dr
Paramus, NJ 07652

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Response to Xing et al.: post-marketing safety concerns with Lecanemab: a pharmacovigilance study based on the FDA adverse event reporting system database.

Response to Xing et al.: post-marketing safety concerns with Lecanemab: a pharmacovigilance study based on the FDA adverse event reporting system database.

Journal: Alzheimer's research & therapy

Published: January 30, 2025

Showing 1-1 of 1

Last Updated: 09/26/2026